Literature DB >> 20375496

Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study.

Saskia H Meves1, Curt Diehm, Klaus Berger, David Pittrow, Hans-Joachim Trampisch, Ina Burghaus, Gerhart Tepohl, Jens-Rainer Allenberg, Heinz G Endres, Markus Schwertfeger, Harald Darius, Roman L Haberl.   

Abstract

BACKGROUND: There is controversial evidence with regard to the significance of peripheral arterial disease (PAD) as an indicator for future stroke risk. We aimed to quantify the risk increase for mortality and morbidity associated with PAD.
METHODS: In an open, prospective, noninterventional cohort study in the primary care setting, a total of 6,880 unselected patients > or =65 years were categorized according to the presence or absence of PAD and followed up for vascular events or deaths over 5 years. PAD was defined as ankle-brachial index (ABI) <0.9 or history of previous peripheral revascularization and/or limb amputation and/or intermittent claudication. Associations between known cardiovascular risk factors including PAD and cerebrovascular mortality/events were analyzed in a multivariate Cox regression model.
RESULTS: During the 5-year follow-up [29,915 patient-years (PY)], 183 patients had a stroke (incidence per 1,000 PY: 6.1 cases). In patients with PAD (n = 1,429) compared to those without PAD (n = 5,392), the incidence of all stroke types standardized per 1,000 PY, with the exception of hemorrhagic stroke, was about doubled (for fatal stroke tripled). The corresponding adjusted hazard ratios were 1.6 (95% confidence interval, CI, 1.1-2.2) for total stroke, 1.7 (95% CI 1.2-2.5) for ischemic stroke, 0.7 (95% CI 0.2-2.2) for hemorrhagic stroke, 2.5 (95% CI 1.2-5.2) for fatal stroke and 1.4 (95% CI 0.9-2.1) for nonfatal stroke. Lower ABI categories were associated with higher stroke rates. Besides high age, previous stroke and diabetes mellitus, PAD was a significant independent predictor for ischemic stroke.
CONCLUSIONS: The risk of stroke is substantially increased in PAD patients, and PAD is a strong independent predictor for stroke. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20375496     DOI: 10.1159/000306640

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  19 in total

1.  A Simple Scale for Screening Lower-Extremity Arterial Disease as a Possible Cause of Low Back Pain: a Cross-sectional Study Among 542 Subjects.

Authors:  M Gahier; J Hersant; J F Hamel; Y Sempore; A Bruneau; S Henni; P Abraham
Journal:  J Gen Intern Med       Date:  2020-05-04       Impact factor: 5.128

2.  Percutaneous transluminal angioplasty for peripheral artery disease confers cardiorenal protection.

Authors:  K Eguchi; A Murakami; T Horaguchi; M Kato; H Miyashita; K Kario
Journal:  J Hum Hypertens       Date:  2013-05-02       Impact factor: 3.012

3.  Axillobifemoral Bypasses: Reappraisal of an Extra-Anatomic Bypass by Analysis of Results and Prognostic Factors.

Authors:  D Dickas; F Verrel; J Kalff; A Koscielny
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

4.  Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle-brachial index, brachial-ankle pulse wave velocity and cardio-ankle vascular index.

Authors:  Naoki Saji; Kazumi Kimura; Yoshiki Yagita; Toshitaka Kawarai; Hirotaka Shimizu; Yasushi Kita
Journal:  Hypertens Res       Date:  2015-02-26       Impact factor: 3.872

5.  The relationship between sex hormones, sex hormone binding globulin and peripheral artery disease in older persons.

Authors:  M Maggio; C Cattabiani; F Lauretani; A Artoni; S Bandinelli; G Schiavi; A Vignali; R Volpi; G Ceresini; G Lippi; R Aloe; F De Vita; F Giallauria; M M McDermott; L Ferrucci; G P Ceda
Journal:  Atherosclerosis       Date:  2012-10-03       Impact factor: 5.162

6.  Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.

Authors:  Michele Massimo Gulizia; Furio Colivicchi; Maurizio Giuseppe Abrignani; Marco Ambrosetti; Nadia Aspromonte; Gabriella Barile; Roberto Caporale; Giancarlo Casolo; Emilia Chiuini; Andrea Di Lenarda; Pompilio Faggiano; Domenico Gabrielli; Giovanna Geraci; Alessio Gaetano La Manna; Aldo Pietro Maggioni; Alfredo Marchese; Ferdinando Maria Massari; Gian Francesco Mureddu; Giuseppe Musumeci; Federico Nardi; Antonio Vittorio Panno; Roberto Franco Enrico Pedretti; Massimo Piredda; Enrico Pusineri; Carmine Riccio; Roberta Rossini; Fortunato Scotto di Uccio; Stefano Urbinati; Ferdinando Varbella; Giovanni Battista Zito; Leonardo De Luca
Journal:  Eur Heart J Suppl       Date:  2018-05-31       Impact factor: 1.803

7.  CHA2DS2-VASc Score and Risk of New-Onset Peripheral Arterial Occlusive Disease in Patients without Atrial Fibrillation.

Authors:  Tzu-Chieh Lin; Ho-Ming Su; Wen-Hsien Lee; Cheng-An Chiu; Nai-Yu Chi; Wei-Chung Tsai; Tsung-Hsien Lin; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu; Po-Chao Hsu
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

8.  To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study.

Authors:  Stein Bergiers; Bert Vaes; Jan Degryse
Journal:  BMC Fam Pract       Date:  2011-05-23       Impact factor: 2.497

9.  The ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke.

Authors:  Joaquín Serena; Tomás Segura; Jaume Roquer; María García-Gil; José Castillo
Journal:  BMC Neurol       Date:  2015-03-11       Impact factor: 2.474

10.  Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort.

Authors:  Maria Teresa Alzamora; Rosa Forés; Guillem Pera; Pere Torán; Antonio Heras; Marta Sorribes; Jose Miguel Baena-Diez; Magalí Urrea; Judit Alegre; María Viozquez; Carme Vela
Journal:  BMC Cardiovasc Disord       Date:  2013-12-17       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.